Vapor products; modifying and adding requirements for certain attestation; requiring certain notice and directing seizure of certain products. Emergency.
SB1102 revises Oklahoma’s vapor product enforcement framework and shifts primary certification oversight from the ABLE Commission to the Attorney General. The bill requires vapor product manufacturers selling into Oklahoma to submit annual attestations under penalty of perjury showing that each product either has a timely filed federal premarket tobacco product application still under review or has received FDA marketing authorization. Manufacturers must list each brand, product, flavor, and category, include supporting FDA documentation, pay a filing fee, and notify the Attorney General of material changes affecting federal authorization status.
The bill creates a public directory of approved manufacturers and vapor products, and it makes it unlawful to sell vapor products in Oklahoma unless they are listed in that directory. It also sets out notice-and-cure procedures before removal from the directory, inventory sell-off periods for retailers and distributors, seizure and destruction authority for noncompliant products, civil penalties, misdemeanor liability for false statements, and special requirements for nonresident or foreign manufacturers, including an in-state agent for service of process and a surety bond. The Attorney General is also directed to conduct compliance checks, adopt rules, and report annually on enforcement and directory activity.
SB1102 also amends Oklahoma’s tobacco tax and licensing statutes to align them with the new vapor product directory system. It updates definitions, requires retailers and wholesalers to buy only from properly licensed sources, authorizes the Tax Commission and law enforcement to inspect, confiscate, and enforce against illicit tobacco and vapor products, and preserves or expands recordkeeping requirements for invoices and transactions. The bill further ties violations to license suspension or revocation and directs enforcement-related fees and penalties into the Tobacco Products Tax Enforcement Unit Revolving Fund.
The general sentiment reflected in the vote history appears supportive but not unanimous. The bill passed the Senate committee unanimously and later passed the Senate floor with a strong majority, then cleared the House committee with a narrower margin. That pattern suggests broad agreement on tightening enforcement and aligning state law with federal vapor product authorization rules, while still drawing some opposition on the floor.
The main points of contention likely center on the bill’s regulatory burden and enforcement reach. Manufacturers face annual fees, detailed product-by-product attestations, bond requirements for nonresident companies, and the risk of product seizure and penalties if federal paperwork or directory status is not in order. Retailers, wholesalers, and distributors are also affected by compliance checks, inventory sell-off deadlines, and liability for selling products not listed in the directory. Supporters likely view these provisions as anti-illicit-trade and youth-access enforcement measures, while critics may see them as restrictive for lawful vapor product businesses and potentially disruptive to market access.
SB1102 substantially amends Oklahoma law governing vapor products and tobacco enforcement by moving certification and directory administration to the Attorney General, creating a statewide approved-product directory, and conditioning lawful sales on inclusion in that directory. It also updates related tobacco tax and licensing statutes in Title 68 to require licensed sourcing, recordkeeping, inspections, confiscation authority, and enforcement coordination for vapor products alongside tobacco products. Manufacturers, wholesalers, retailers, importers, and nonresident foreign manufacturers are all directly affected by new filing, notice, fee, bond, and compliance obligations.
The bill’s vote history suggests generally favorable sentiment toward stronger vapor product regulation and enforcement, with unanimous committee support in the Senate and a solid Senate floor majority. The House committee vote was closer, indicating some reservations, but the overall trajectory shows the measure had enough support to advance. The absence of recorded committee debate makes it difficult to identify specific arguments, but the pattern suggests the bill was viewed as an enforcement and public-safety measure rather than a purely punitive one.
Likely areas of contention include the shift of authority from the ABLE Commission to the Attorney General, the cost and administrative burden on manufacturers, and the practical effect of banning sales of products not listed in the directory. Foreign and nonresident manufacturers may object to the in-state agent and surety bond requirements, while retailers and distributors may be concerned about inventory losses, seizure risk, and compliance-check enforcement. Opponents may also question whether the bill could reduce product availability or create uncertainty for products awaiting federal FDA review.